| Dr Jeff R Mason, MD | |
|
1100 Pacific Ave, Suite 300, Everett, WA 98201-4261 | |
| (425) 339-2433 | |
| (425) 339-8273 |
| Full Name | Dr Jeff R Mason |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 1100 Pacific Ave, Everett, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174592588 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD00030797 (Washington) | Primary |
| Entity Name | Proliance Surgeons Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023170313 PECOS PAC ID: 8527972900 Enrollment ID: O20031119000128 |
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Electroconvulsive therapy helps people with severe depression by "pushing the reset button" on brain networks involved in creating a mental picture, according to recent Baycrest findings.
Realton Corporation, a pioneer in developing diode-pumped laser systems initially targeted to treat enlarged prostate, today announced the closing of its Series B financing co-led by OrbiMed Advisors and China Healthcare Partnership. Existing investor CSV Capital Partners will also participate in the financing. The financing will be used primarily to enhance Realton's marketing and distribution networks, expand its manufacturing capabilities and pursue new technology development.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Allan Coukell, director of medical programs for the Pew Health Group, issued the following statement today on a U.S. Senate Health, Education, Labor & Pensions Committee hearing, "FDA User Fees: Advancing Public Health."
› Verified 4 days ago
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Electroconvulsive therapy helps people with severe depression by "pushing the reset button" on brain networks involved in creating a mental picture, according to recent Baycrest findings.
Realton Corporation, a pioneer in developing diode-pumped laser systems initially targeted to treat enlarged prostate, today announced the closing of its Series B financing co-led by OrbiMed Advisors and China Healthcare Partnership. Existing investor CSV Capital Partners will also participate in the financing. The financing will be used primarily to enhance Realton's marketing and distribution networks, expand its manufacturing capabilities and pursue new technology development.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Allan Coukell, director of medical programs for the Pew Health Group, issued the following statement today on a U.S. Senate Health, Education, Labor & Pensions Committee hearing, "FDA User Fees: Advancing Public Health."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeff R Mason, MD 805 Madison St, Suite 901, Seattle, WA 98104-1172 Ph: (206) 264-8100 | Dr Jeff R Mason, MD 1100 Pacific Ave, Suite 300, Everett, WA 98201-4261 Ph: (425) 339-2433 |
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Electroconvulsive therapy helps people with severe depression by "pushing the reset button" on brain networks involved in creating a mental picture, according to recent Baycrest findings.
Realton Corporation, a pioneer in developing diode-pumped laser systems initially targeted to treat enlarged prostate, today announced the closing of its Series B financing co-led by OrbiMed Advisors and China Healthcare Partnership. Existing investor CSV Capital Partners will also participate in the financing. The financing will be used primarily to enhance Realton's marketing and distribution networks, expand its manufacturing capabilities and pursue new technology development.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Allan Coukell, director of medical programs for the Pew Health Group, issued the following statement today on a U.S. Senate Health, Education, Labor & Pensions Committee hearing, "FDA User Fees: Advancing Public Health."
› Verified 4 days ago
Dr. John D Pryor, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 Pacific Ave, Suite 300, Everett, WA 98201 Phone: 425-339-2433 Fax: 425-339-8273 | |
Dr. Richard L Semon, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1100 Pacific Ave, Suite 300, Everett, WA 98201 Phone: 425-339-2433 Fax: 425-339-8273 | |
Dr. Peter J. Kinahan, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1100 Pacific Ave, Suite 300, Everett, WA 98201 Phone: 425-339-2433 Fax: 425-339-8273 | |
Dr. Alireza K Anissipour, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3726 Broadway, Suite 201, Everett, WA 98201 Phone: 425-317-9119 | |
Dr. Douglas D Nowak, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1100 Pacific Ave, Suite 300, Everett, WA 98201 Phone: 425-339-2433 Fax: 425-339-8273 | |
Nicholas John Vaudreuil, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 Pacific Ave Ste 300, Everett, WA 98201 Phone: 425-339-2433 Fax: 425-339-8273 | |
Dr. Howard Barnum Barker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 Pacific Ave, Suite 300, Everett, WA 98201 Phone: 425-339-2433 Fax: 425-339-8273 |